BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Loading...
Loading...

Prasugrel patents preparation Pages on BioPortfolio:

BioPortfolio - sanofi-synthelabo
sanofi-synthelabo Patents:. US Patent No. Title. 6573381, Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates ...
http://www.bioportfolio.com/biocorporate/9150-sanofi-synthel...

Results from other life science and pharmaceutical sites:

Prasugrel, a third generation thienopyridine and potent platelet ...
More recent patents relating to prasugrel have been ..... thereof and their preparation and uses for inhibiting blood platelet. aggregation. ...
http://www.biomedcentral.com/content/pdf/cd-881124.pdf...

BioPortfolio - sanofi-synthelabo
sanofi-synthelabo Patents:. US Patent No. Title. 6573381, Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates ...
http://www.bioportfolio.com/biocorporate/9150-sanofi-synthel...

cd-881124 Review Prasugrel, a third generation thienopyridine and ...
Patent summary Prasugrel is specifically claimed as novel in claim 21 of .... and their preparation and uses for inhibiting blood platelet aggregation. ...
http://www.biomedcentral.com/content/download/xml/cd-881124....

Newsroom
FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel .... Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents ...
http://www.prnewswire.com/micro/lly...

Health Care/Hospital News News Archive - Yahoo! Finance
1:32 pm - PR Newswire; HHS Supports Medical Evacuations in Preparation for Hurricane ... 10:48 am - PR Newswire; Prasugrel Head-to-Head Study Showed
Reduced ...
http://biz.yahoo.com/n/y/y0015.html...

Hartford Hospital/UCONN Cardiovascular Fellowship - PROGRAM ...
preparation of a research project. Research is begun in the first year ..... comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 ...
http://www.harthosp.org/Portals/1/Images/63/cardiovascular_f...

Eli Lilly and Company 2006 Annual Report, Notice of 2007 Annual ...
upheld an earlier ruling that had affirmed Lilly’s patent. on Zyprexa. .... study—a head-to-head superiority trial of prasugrel against ...
http://www.lilly.com/investor/annual_report/lillyar2006.pdf...

The application of discovery toxicology and pathology towards the ...
The design, preparation and SAR of novel small molecule sodium (Na(+)) .... Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel
...
http://www.nature.com/nrd/journal/v6/n8/full/nrd2378.html...

Eli Lilly and Company Answers for Shareholders 2005
this study is to determine whether prasugrel—a platelet ...... patent on Zyprexa . In the case of Eli Lilly and Company v. Zenith Goldline Pharmaceuticals et ...
http://www.lilly.com/investor/annual_report/lillyar2005.pdf...

The Academic Anesthesiology Committee
prasugrel are considered, as well as their potential role in ...... The somatostatin analogue, Octreotide used in the preparation and management ...
http://www.umassmed.edu/uploadedFiles/NEARC%202007%20Program...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo